tes introduced significant variability, leading to failed experiments and production failures. Zap-CHO addresses these concerns and provides significant benefits in CHO cell culture, including:
*Faster cell line development and seed train expansion
*Animal component-free media
*Consistency of a defined media component
*Biomanufacturing optimization and improved production economics
*Better and more predictable performance in cell culture research and development
Now, with Zap-CHO, customers can get the animal free benefit of hydrolysates, the performance of FBS and the consistency of a defined media, said Randy Semadeni, InVitrias Vice President of Business Development. It is a new era for the cell culture industry.
About InVitria - www.InVitria.com
InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture media components and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research, medical devices and diagnostics.
Page: 1 2 Related biology news :1
For more information about InVitrias products or to obtain a copy of Dr. Pettits Zap-CHO poster or presentation, please contact InVitria at email@example.com or call 1-800-916-8311.
. InVitria Successfully Completes Beta Testing and Announces Commercial Launch of Optiferrin for Mammalian Cell Culture2
. InVitria Sponsors ESACT 2009 in Dublin, Ireland3
. InVitria to Unveil Powerful Cell Culture Media Component ZAP-CHO4
. InVitria Announces Launch of Recombinant Albumin for Diagnostics5
. The BBVA Foundation presents its Frontiers of Knowledge Awards6
. Versartis presents positive preclinical data on 2 product candidates at ENDO 097
. REGiMMUNE presents enhanced efficacy data in preclinical transplantation models8
. Biolex presents Locteron US Phase 2a hepatitis C data at EASL9
. GSA special paper presents new studies of Western US earth motion10
. AIUM Presents 2009 Joseph H. Holmes Pioneer Awards11
. AIUM presents 2009 Memorial Hall of Fame awards